Tsiknakis Manolis, Brochhausen Mathias, Nabrzyski Jarek, Pucacki Juliusz, Sfakianakis Stelios G, Potamias George, Desmedt Cristine, Kafetzopoulos Dimitris
Foundation for Research and Technology-Hellas, Institute of Computer Science, GR-71110 Heraklion, Greece.
IEEE Trans Inf Technol Biomed. 2008 Mar;12(2):205-17. doi: 10.1109/TITB.2007.903519.
This paper reports on original results of the Advancing Clinico-Genomic Trials on Cancer integrated project focusing on the design and development of a European biomedical grid infrastructure in support of multicentric, postgenomic clinical trials (CTs) on cancer. Postgenomic CTs use multilevel clinical and genomic data and advanced computational analysis and visualization tools to test hypothesis in trying to identify the molecular reasons for a disease and the stratification of patients in terms of treatment. This paper provides a presentation of the needs of users involved in postgenomic CTs, and presents such needs in the form of scenarios, which drive the requirements engineering phase of the project. Subsequently, the initial architecture specified by the project is presented, and its services are classified and discussed. A key set of such services are those used for wrapping heterogeneous clinical trial management systems and other public biological databases. Also, the main technological challenge, i.e. the design and development of semantically rich grid services is discussed. In achieving such an objective, extensive use of ontologies and metadata are required. The Master Ontology on Cancer, developed by the project, is presented, and our approach to develop the required metadata registries, which provide semantically rich information about available data and computational services, is provided. Finally, a short discussion of the work lying ahead is included.
本文报告了癌症临床基因组试验推进综合项目的原始成果,该项目专注于设计和开发欧洲生物医学网格基础设施,以支持癌症多中心后基因组临床试验(CTs)。后基因组CTs使用多层次临床和基因组数据以及先进的计算分析和可视化工具来检验假设,试图确定疾病的分子原因以及患者在治疗方面的分层情况。本文介绍了参与后基因组CTs的用户需求,并以场景的形式呈现这些需求,这些场景推动了项目的需求工程阶段。随后,展示了项目指定的初始架构,并对其服务进行了分类和讨论。这类服务的一组关键服务是用于包装异构临床试验管理系统和其他公共生物数据库的服务。此外,还讨论了主要的技术挑战,即语义丰富的网格服务的设计和开发。为实现这一目标,需要大量使用本体和元数据。介绍了该项目开发的癌症主本体,并提供了我们开发所需元数据注册表的方法,这些注册表提供了有关可用数据和计算服务的语义丰富信息。最后,对未来的工作进行了简短讨论。